Antimicrobial Chemotherapy Conference

London, 2019

15 January, Seligman Theatre, Royal College of Physicians

Welcome to the Antimicrobial
Chemotherapy Conference 2019: An ABC for everyone involved in developing new antimicrobials

In collaboration with Global Antibiotic Research & Development Partnership (GARDP)


Full timings and details will be available shortly on the downloadable programme

Download Programme
Opening remarks
Professor Laura Piddock, Head of Scientific Affairs, Global Antibiotic R&D Partnership (GARDP)

SESSION ONE: Antimicrobial drug discovery - an essential overview
The risks of clinical development from the perspective of the antibacterial discovery scientist
Dr David Shlaes, Former Professor of Medicine, Case Western Reserve University, Ohio, USA
Overview of new antibiotics in development
Professor David Livermore, Professor of Medical Microbiology, University of East Anglia
Overview of new antifungals in development
Professor David Denning, Professor of Infectious Diseases in Global Health, University of Manchester

SESSION TWO: Things we forget that come back to bite us!
Things clinicians don’t often consider (CMC, GLP toxicology, Phase I studies)
Dr Lauren Walker, Clinical Lecturer at Royal Liverpool University Hospital
PK-PD programs for drug development
Professor George Drusano, University of Florida and an Institute Director (Institute for Therapeutic Innovation)
Invited paper – Identifying carbapenem and amikacin-sparing first-line combination therapy for neonatal sepsis in high extended-spectrum beta-lactamase (ESBL) prevalence settings
Dr Joe Standing, Principal Research Associate (MRC fellow), UCL Great Ormond Street Institute of Child Health
Invited paper – Light controlled release of antimicrobial peptides for the treatment of pathogenic bacteria
Samuel Moorcroft, PhD Student, University of Leeds

SESSION THREE: Tackling Beta-lactamase mediated resistance
Beta-lactamase inhibition: A potted history of beta lactamase and lessons from recent development of beta-lactamase inhibiter combinations
Dr Shampa Das, Senior Lecturer, Molecular and Clinical Pharmacology, University of Liverpool
Metallobetalactamases and development of new compounds
Dr Martin Everett, Chief Scientific Officer, Antabio
Invited paper - REVIVE – a programme to support and connect the antimicrobial R&D community
Astrid Pentz-Murr, Community manager REVIVE, GARDP

SESSION FOUR: The Way Forward: Clinical Trial Design and New Drug Development
Stimulating Antibiotic R&D through links to sustainable use and novel economic incentives
Dr Ursula Theuretzbacher, Founder, Center for Anti-Infective Agents
Developing a new drug for STIs
Dr Emilie Alirol, Project Leader, Sexually Transmitted Infections, Global Antibiotic R&D Partnership (GARDP)
Innovative clinical trial design for unmet clinical needs: neonatal sepsis
Dr Julia Bielicki, Consultant in Paediatric Infectious Diseases, Lead Physician Infection Prevention and Control University of Basel Children’s Hospital
Clinical Trial Design for new antimicrobials: adults
Mr Aaron Dane, Director, DaneStat Consulting Limited

Posters & Abstracts

Abstract submission is now OPEN
All accepted abstracts (oral and poster) will receive complimentary registration at this event and (for students and trainees) the BSAC 2019 Spring Conference. The deadline for funded applications is Friday 14 December 2018.

If you wish to submit an abstract for poster presentation please submit to Esme Carruthers at for consideration using the template below.

All abstract authors will be notified of acceptance. If you submitted an abstract but have not received a response please contact

Deadline for Oral submissions – Friday 16 November 2018
Deadline for Poster submissions – Friday 14 December 2018.

Please note poster presentations should be printed in size A1, portrait orientation.


Register for the event now

Please select your registration category from the options below and click to register online.

Alternatively you can download a registration form here and return to Esme Carruthers at or by post to Esme Carruthers, Events Manager, BSAC, 53 Regent Place, Birmingham, B1 3NJ.

All accepted abstracts (oral and poster) will receive complimentary registration at this event and (for students and trainees) the BSAC 2019 Spring Conference. The deadline for funded applications is Friday 14 December 2018.

BSAC Members receive a 20% discount on all registration fees.

*All prices below are inclusive of VAT
**The deadline for funded place applications is Friday 14 December 2018


Please contact Debbie Cockayne at for more information.

Venue & Travel

Seligman Theatre, Royal College of Physicians, London, NW1 4LE

The RCP is the ideal London location for high profile conferences, presentations and exhibitions. There is an impressive portfolio of purpose-designed conferencing facilities including dedicated registration areas, tiered auditoriums, meeting rooms, exhibition spaces and dining areas.

The Royal College of Physicians is located in Regent’s Park close to the centre of London with great transport links, and high quality local hotels and restaurants. The elegant spacious building was purpose built for lectures in 1959 by award winning architect Sir Deny Lasdun.

Arriving by Train
Euston station (15 mins walk)
King’s Cross and St Pancras stations
National and International rail services (5 minutes by taxi)
Marylebone station (5 minutes by taxi)

Arriving by underground
_Regent’s Park station on the Bakerloo line (5 minutes walk)
Great Portland Street Station on the Circle, Metropolitan and Hammersmith and City lines (5 minutes walk)
Warren Street Station on the Victoria and Northern lines (10 minutes walk)

Arriving by bus
A – Routes: 18, 27, 30, 205, 453
B – Routes: C2
C – Routes: 18, 27, 30, 205
D – Routes: 18, 27, 30, 205, 453

Arriving by car
Easy access via M40 and M1
Car Parking: The RCP offers free parking to disabled guests by prior arrangement and is situated outside the congestion charge zone. The nearest public car park is a few minutes walk away (refer to the map)

© Copyright 2018
British Society for Antimicrobial Chemopherapy.

By using this site, you agree to using cookies. For more details about cookies and how to disable them, see our cookie page